Vascular Consideration with COVID-19 Vaccination: Clinical Case Report

Haj Abdo M*, Yildirim-Ögüt Z, Housen H, Zistler K, Boulhadid A, Kolletas V, Kadriu E and Seidl K

Department of Cardiology and Intensive Care Unit, The Clinic of Ingolstadt, Germany

^*Correspondance to: Mourad Haj Abdo 

 PDF  Full Text Case Report | Open Access

Abstract:

Coronavirus Disease 2019 (COVID-19), the illness caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to cause significant morbidity and mortality over the World. Globally; numerous vaccines have been developed against COVID-19. In Europe and United states, four vaccines have been approved by the FDA. The Majority of people become Moderna and Pfizer-BioNTech, although certainly side effect may occur, the benefit greatly outweigh the risks. Adverse cardiovascular side effects of the COVID-19 vaccine include myocarditis/pericarditis, Vaccine Induced Thrombotic Thrombocytopenia (VITT) and thromboses, which often related to low platelet levels and VITT in the setting.

Keywords:

Cite the Article:

Haj Abdo M, Yildirim-Ögüt Z, Housen H, Zistler K, Boulhadid A, Kolletas V, et al. Vascular Consideration with COVID-19 Vaccination: Clinical Case Report. Ann Clin Case Rep. 2022; 7: 2251.